There is an ever-expanding need for SARS-CoV-2 antivirals. A recent analysis suggests fluvoxamine may greatly reduce the risk of hospitalization in Covid patients.
Subscribe to:
Post Comments (Atom)
< + > A Demo of Truven Health Insights Turning Data Into Actionable Insights
Renee Wiczorek, Lead Product Manager at Truven by Merative , wants healthcare institutions to ask the deep questions about the trends they’...
No comments:
Post a Comment